BMI OrganBank Teams Up With Dedicated Staffing Solutions for Enhanced Organ Preservation Technology BMI OrganBank has formed a strategic alliance with Dedicated Staffing Solutions, enhancing organ preservation and clinical expertise in transplantation.

BMI OrganBank Teams Up With Dedicated Staffing Solutions for Enhanced Organ Preservation Technology #USA #Winston-Salem #BMI_OrganBank #organ_preservation #Dedicated_Staffing_Solutions

Bridge to Life™ Achieves Historical Approval for Advanced Organ Preservation Technology Bridge to Life™ Ltd. celebrates a significant FDA De Novo clearance for its VitaSmart™ System, transforming liver transplant preservation with innovative technology.

Bridge to Life™ Achieves Historical Approval for Advanced Organ Preservation Technology #United_States #Duluth #FDA_Clearance #VitaSmart™ #organ_preservation

Bridge to Life Achieves FDA Approval for Innovative VitaSmart™ Hypothermic Oxygenated Perfusion System Bridge to Life™ has received FDA De Novo clearance for its VitaSmart™ system, advancing liver preservation techniques in transplantation with enhanced organ viability.

Bridge to Life Achieves FDA Approval for Innovative VitaSmart™ Hypothermic Oxygenated Perfusion System #USA #FDA_Approval #Duluth #VitaSmart™ #organ_preservation

Vascular Perfusion Solutions Partners with Harvard's Wyss Institute for Organ Preservation Innovations Vascular Perfusion Solutions teams with Harvard's Wyss Institute to enhance organ preservation through advanced biostasis compounds, advancing healthcare access.

Vascular Perfusion Solutions Partners with Harvard's Wyss Institute for Organ Preservation Innovations #United_States #San_Antonio #organ_preservation #Vascular_Perfusion_Solutions #Wyss_Institute

Global Organ Preservation Market Projected to Reach $0.3 Billion by 2030 with a Steady Growth Rate The organ preservation market is expected to grow significantly, reaching $0.3 billion by 2030, driven by chronic diseases and improved transplant technologies.

Global Organ Preservation Market Projected to Reach $0.3 Billion by 2030 with a Steady Growth Rate #USA #Delray_Beach #organ_preservation #UW_Solution #Custodiol_HTK

Bridge to Life™ Reveals Innovative 12-Month Clinical Trial Findings on HOPE at World Transplant Congress 2025 At the World Transplant Congress 2025, Bridge to Life™ Ltd. showcased vital data from its 12-month clinical trial on hypothermic oxygenated perfusion (HOPE), highlighting breakthroughs in liver preservation.

Bridge to Life™ Reveals Innovative 12-Month Clinical Trial Findings on HOPE at World Transplant Congress 2025 #USA #San_Francisco #Bridge_to_Life #organ_preservation #HOPE_Trial

Bridge to Life™ Unveils Groundbreaking HOPE Trial Data at 2025 World Transplant Congress Bridge to Life™ showcased revolutionary 12-month clinical trial results on HOPE at the World Transplant Congress 2025, emphasizing organ preservation technology.

Bridge to Life™ Unveils Groundbreaking HOPE Trial Data at 2025 World Transplant Congress #USA #San_Francisco #Bridge_to_Life #organ_preservation #Hope

Bridge to Life™ Presents Groundbreaking Clinical Data at 2025 World Transplant Congress At the 2025 World Transplant Congress in San Francisco, Bridge to Life™ will present innovative 12-month clinical study data, showcasing their advancements in organ preservation technology.

Bridge to Life™ Presents Groundbreaking Clinical Data at 2025 World Transplant Congress #USA #San_Francisco #organ_preservation #Hope #Bridge_to_Life™

Bridge to Life Expands EasiSlush® Sodium Chloride Solution Indications with FDA Clearance Bridge to Life™ Ltd. has announced the FDA's 510K Clearance for EasiSlush®, enhancing its use in various surgical procedures, supporting organ transplant efforts.

Bridge to Life Expands EasiSlush® Sodium Chloride Solution Indications with FDA Clearance #United_States #Chicago #Bridge_to_Life #organ_preservation #EasiSlush®

Bridge to Life Announces Key Presentations at ILTS 2025 in Singapore Bridge to Life Ltd will showcase significant abstracts at the upcoming ILTS 2025 congress in Singapore, highlighting advancements in organ preservation technology.

Bridge to Life Announces Key Presentations at ILTS 2025 in Singapore #None #Singapore #Bridge_to_Life #organ_preservation #ILTS

Bridge to Life to Present Innovative Research at ILTS 2025 in Singapore Bridge to Life Ltd. will showcase nine abstracts at the ILTS 2025 Congress in Singapore, focusing on groundbreaking liver transplant technologies.

Bridge to Life to Present Innovative Research at ILTS 2025 in Singapore #USA #Chicago #Bridge_to_Life #ILTS_2025 #organ_preservation